Motion Sickness Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Conditions:   Motion Sickness, Space;   Motion Sickness;   Sea Sickness Interventions:   Drug: DPI-386 Nasal Gel;   Drug: Placebo Nasal Gel Sponsors:   Repurposed Therapeutics, Inc.;   National Aeronautics and Space Administration (NASA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials

Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Conditions:   Motion Sickness, Space;   Motion Simulation;   Parabolic Flight Interventions:   Drug: DPI-386 Nasal Gel;   Drug: Other (e.g., promethazine, meclizine) Sponsors:   Repurposed Therapeutics, Inc.;   National Aeronautics and Space Administration (NASA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2023 Category: Research Source Type: clinical trials